Terson's syndrome in a patient with acute promyelocytic leukemia on all-trans retinoic acid treatment Abstract
The syndrome of vitreous hemorrhage in association with any form of intracranial bleeding is known as Terson's syndrome. Acute promyelocytic leukemia (APL) constitutes 5% to 15% of cases of acute nonlymphocytic leukemias, in which hemorrhagic diathesis often occurs and results in a rapid fatal outcome. In this report we describe a patient with APL who developed cerebral bleeding in association with bilateral subhyaloid and vitreous hemorrhages consistent with Terson's syndrome while she was on all-trans retinoic acid induction therapy.
Key words All-trans retinoic acid Cerebral hemorrhage Intraocular hemorrhage Leukemia Retinopathy Terson's syndrome References
Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukemia. Br J Haematol 1976; 33: 451–58.
Gralnick HR, Sultan C. Acute promyelocytic leukemia: hemorrhagic manifestation and morphologic criteria. Br J Haematol 1975; 29: 373–79.
Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–80.
Chomienne C, Ballerini P, Balitrand N, et al. The retinoic acid receptor and gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. Leukemia 1990; 4: 802–7.
Meng-er H, Yu-chen Y, Shu-rong C, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–72.
Terson A. De l'hemorrhagie dans le corps vitre au course de l'hemorrhagie cerebrale. Clin Ophthalmol 1900; 6: 309–12.
Schultz PN, Sobel WM, Weingeist TA. Long term visual outcome in Terson syndrome. Ophthalmology 1991; 98: 1814–19.
Weingeist TA, Goldman EJ, Fold JC, Packer AJ, Ossoinig KC. Terons's syndrome: Clinicopathological correlations. Ophthalmology 1986; 93: 1435–42.
Schachat AP. The leukemias and lymphomas. In: Ryan SJ, ed. Retina, Vol 1. St. Louis: CV Mosby, 1989: 775–91.
Collins AJ, Bloomfield CD, Peterson BA, McKenna RW, Edson R. Acute promyelocytic leukemia: Management of the coagulopathy during daunorubicinprednisone remission induction. Arch Intern Med 1978; 138: 1677–85.
Gralnick HR, Abrell E. Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukemia. Br J Haematol 1973; 24: 89–96.
Sultan C, Heilmann-Gouault M, Tulliez M. Relationship between blast-cell morphology and occurrence of a syndrome of disseminated intravascular coagulation. Br J Haematol 1973; 23: 255–61.
Cordonnier C, Vernant JP, Brun B, et al. Acute promyelocytic leukemia in 57 previously untreated patients. Cancer 1985; 55: 18–22.
Fenaux P, Castaigne S, Dombret H. All-trans retinoic acid (ATRA) as first line therapy of acute promyelocytic leukemia (APL). A report of 31 cases. Br J Haematol 1991; 77 (Abstract).
Google Scholar Copyright information
© Kluwer Academic Publishers 1993